DecisionMap Wealth Management LLC grew its position in shares of Procter & Gamble Company (The) (NYSE:PG - Free Report) by 49.2% in the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 9,155 shares of the company's stock after purchasing an additional 3,019 shares during the period. Procter & Gamble makes up approximately 1.0% of DecisionMap Wealth Management LLC's investment portfolio, making the stock its 26th biggest position. DecisionMap Wealth Management LLC's holdings in Procter & Gamble were worth $1,459,000 at the end of the most recent reporting period.
Other hedge funds also recently made changes to their positions in the company. B & T Capital Management DBA Alpha Capital Management increased its stake in Procter & Gamble by 2.3% in the 1st quarter. B & T Capital Management DBA Alpha Capital Management now owns 2,795 shares of the company's stock worth $476,000 after acquiring an additional 63 shares during the last quarter. Private Management Group Inc. grew its holdings in shares of Procter & Gamble by 4.8% in the first quarter. Private Management Group Inc. now owns 1,384 shares of the company's stock valued at $236,000 after purchasing an additional 64 shares in the last quarter. Lantz Financial LLC increased its position in Procter & Gamble by 1.2% in the second quarter. Lantz Financial LLC now owns 5,237 shares of the company's stock worth $834,000 after purchasing an additional 64 shares during the last quarter. Orca Investment Management LLC raised its stake in Procter & Gamble by 2.0% during the second quarter. Orca Investment Management LLC now owns 3,238 shares of the company's stock valued at $516,000 after purchasing an additional 64 shares in the last quarter. Finally, Detalus Advisors LLC lifted its position in Procter & Gamble by 0.8% during the first quarter. Detalus Advisors LLC now owns 7,918 shares of the company's stock valued at $1,349,000 after purchasing an additional 65 shares during the last quarter. 65.77% of the stock is currently owned by hedge funds and other institutional investors.
Procter & Gamble Price Performance
PG opened at $151.98 on Tuesday. The business has a fifty day moving average of $154.86 and a 200 day moving average of $158.59. The stock has a market cap of $355.72 billion, a P/E ratio of 23.35, a PEG ratio of 4.02 and a beta of 0.36. The company has a quick ratio of 0.49, a current ratio of 0.70 and a debt-to-equity ratio of 0.49. Procter & Gamble Company has a 52-week low of $146.96 and a 52-week high of $180.43.
Procter & Gamble (NYSE:PG - Get Free Report) last released its earnings results on Tuesday, July 29th. The company reported $1.48 earnings per share for the quarter, topping the consensus estimate of $1.42 by $0.06. The business had revenue of $20.89 billion during the quarter, compared to the consensus estimate of $20.79 billion. Procter & Gamble had a return on equity of 32.69% and a net margin of 18.95%.The business's revenue for the quarter was up 1.7% compared to the same quarter last year. During the same period last year, the company earned $1.40 earnings per share. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. As a group, sell-side analysts anticipate that Procter & Gamble Company will post 6.91 EPS for the current year.
Procter & Gamble Announces Dividend
The business also recently announced a quarterly dividend, which will be paid on Monday, November 17th. Stockholders of record on Friday, October 24th will be given a dividend of $1.0568 per share. The ex-dividend date of this dividend is Friday, October 24th. This represents a $4.23 dividend on an annualized basis and a dividend yield of 2.8%. Procter & Gamble's dividend payout ratio (DPR) is 64.82%.
Insider Activity
In other news, insider Balaji Purushothaman sold 490 shares of the firm's stock in a transaction on Thursday, October 2nd. The stock was sold at an average price of $152.23, for a total transaction of $74,592.70. Following the transaction, the insider owned 12,616 shares in the company, valued at approximately $1,920,533.68. This trade represents a 3.74% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, CEO Jennifer L. Davis sold 3,227 shares of the company's stock in a transaction dated Thursday, October 2nd. The stock was sold at an average price of $152.23, for a total transaction of $491,246.21. Following the completion of the sale, the chief executive officer directly owned 61,764 shares of the company's stock, valued at approximately $9,402,333.72. This trade represents a 4.97% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 149,763 shares of company stock valued at $23,421,279. Insiders own 0.20% of the company's stock.
Analyst Upgrades and Downgrades
Several analysts have recently issued reports on PG shares. Evercore ISI restated an "in-line" rating and set a $170.00 target price (down from $190.00) on shares of Procter & Gamble in a research report on Monday, July 14th. Barclays decreased their price objective on Procter & Gamble from $164.00 to $153.00 and set an "equal weight" rating on the stock in a research report on Wednesday, October 1st. UBS Group dropped their target price on Procter & Gamble from $180.00 to $176.00 and set a "buy" rating for the company in a report on Wednesday, October 8th. Weiss Ratings restated a "hold (c+)" rating on shares of Procter & Gamble in a report on Wednesday, October 8th. Finally, Bank of America dropped their price objective on shares of Procter & Gamble from $180.00 to $174.00 and set a "buy" rating for the company in a research note on Wednesday, October 8th. Eleven research analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and a consensus target price of $171.68.
View Our Latest Report on PG
About Procter & Gamble
(
Free Report)
Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.
Featured Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Procter & Gamble, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.
While Procter & Gamble currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.